Latest News
First effective treatment to prevent multidrug-resistant TB
An oral antibiotic taken once daily for six months can substantially reduce the risk of developing multidrug-resistant (MDR) tuberculosis (TB) in both children and adults, according to two landmark clinical trials.
Taking PrEP improves wellbeing
Qualitative data from PROUD study provides first look at the psychological and social impacts of taking oral PrEP among gay men in England.
MRC CTU at UCL and collaborators at the International Society of Blood Transfusion 2023 conference
Researchers from the MRC Clinical Trials Unit at UCL and our partner institutes will share highlights from our TRACT blood transfusion clinical trial.
Our research at The Union World Conference on Lung Health
MRC Clinical Trials Unit at UCL researchers and collaborators will present the latest advances in our tuberculosis clinical trials at the Union 2023 conference in Paris.
Peter Godolphin wins Prostate Cancer Foundation Young Investigator Award
The fellowship is awarded to future research leaders in the field of prostate cancer research.